Long-term outcome and characteristics of patients with NSTEMI and non-obstructive coronary arteries

医学 狼牙棒 心脏病学 心肌梗塞 内科学 冠状动脉 血脂异常 临床终点 肌钙蛋白 狭窄 血运重建 冠状动脉疾病 动脉 疾病 经皮冠状动脉介入治疗 临床试验
作者
F. Boukerche,L. Zouli,N. Laredj
出处
期刊:Archives of Cardiovascular Diseases [Elsevier]
卷期号:117 (1): S17-S18
标识
DOI:10.1016/j.acvd.2023.10.032
摘要

Discordant data have been reported on the prognosis of myocardial infarction with nonobstructive coronary arteries (MINOCA). The objectives of this study were to assess characteristics and prognostic impact on the long-term follow-up of the diagnosis of MINOCA. We included 274 consecutive patients with non–ST-segment elevation myocardial infarction (NSTEMI) who underwent coronary angiography between November 2015 and October 2016. MINOCA was classified according to angiographic findings as smooth coronary arteries, mild irregularities (< 30% stenosis), and moderate atherosclerosis (30%–49% stenosis). The primary endpoint was a composite of cardiovascular mortality, nonfatal myocardial infarction, and revascularization (MACE) at a median of 6 years of follow-up. A total of 74 patients (27.0%) showed no obstructive lesions. Patients with MINOCA are characterized by younger age, a predominance of females, less diabetes mellitus, dyslipidemia, and smoking, lower GRACE score at admission, less marked electrocardiographic and echocardiographic changes, and lower troponin levels (Table 1). MINOCA was associated with a lower occurrence of MACE (P < 10-3; HR, 0.085; 95%CI, 0.031–0.231) (Figure 1) and was confirmed as an independent factor in the multivariate analysis (P < 10-3; HR, 0.121; 95%CI, 0.042–0.354). On analysis of the separate components of the main endpoint, MINOCA was significantly associated with a lower rate of cardiovascular mortality, myocardial infarction, and revascularization. MINOCA is characterized by a low-risk profile at admission except for the positivity of troponin and is associated with a lower rate of MACE at the long-term follow-up.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
66应助马佳凯采纳,获得10
刚刚
林溪完成签到,获得积分10
刚刚
Amber应助CTX采纳,获得10
刚刚
lan完成签到 ,获得积分10
刚刚
共享精神应助Elaine采纳,获得10
2秒前
2秒前
安静一曲完成签到 ,获得积分10
2秒前
3秒前
完美世界应助嘎嘎顺利采纳,获得10
3秒前
崔靥完成签到,获得积分10
3秒前
4秒前
阿敏关注了科研通微信公众号
4秒前
一只绒可可完成签到,获得积分10
4秒前
CBY完成签到,获得积分10
4秒前
4秒前
QYPANG完成签到,获得积分10
5秒前
子时月完成签到,获得积分10
6秒前
脑洞疼应助xlx采纳,获得10
6秒前
jym完成签到,获得积分10
6秒前
6秒前
田様应助笑点低蜜蜂采纳,获得10
6秒前
今后应助乐观的一一采纳,获得10
7秒前
开朗向真完成签到,获得积分10
7秒前
7秒前
奋斗映寒发布了新的文献求助10
7秒前
梓榆发布了新的文献求助10
7秒前
帅气的沧海完成签到 ,获得积分10
7秒前
8秒前
FashionBoy应助包容的幻梅采纳,获得10
8秒前
8秒前
qaq完成签到,获得积分10
8秒前
8秒前
voyager完成签到,获得积分10
8秒前
勇敢肥猫发布了新的文献求助10
9秒前
YA发布了新的文献求助10
9秒前
10秒前
10秒前
10秒前
orixero应助玉yu采纳,获得10
10秒前
11秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527521
求助须知:如何正确求助?哪些是违规求助? 3107606
关于积分的说明 9286171
捐赠科研通 2805329
什么是DOI,文献DOI怎么找? 1539901
邀请新用户注册赠送积分活动 716827
科研通“疑难数据库(出版商)”最低求助积分说明 709740